Bacteriophage T4 as a Protein-Based, Adjuvant- and Needle-Free, Mucosal Pandemic Vaccine Design Platform

Keyphrases

• Protein-based 100%
• Vaccine Platform 100%
• Vaccine Design 100%
• Adjuvant-free 100%
• Bacteriophage T4 100%
• Needle-free 100%
• Pandemic Vaccine 100%
• Design Platform 100%
• Immune Response 50%
• Binding Protein 50%
• Sterilizing Immunity 50%
• Mucosal Immunity 50%
• Cellular Response 50%
• Next-generation Vaccines 50%
• High Cost 50%
• Mucosal Response 50%
• Viral Pathogens 50%
• Phage 50%
• Thermal Instability 50%
• Vaccinology 50%
• Novel Protein 50%
• Bacterial Pathogens 50%
• COVID-19 Pandemic 50%
• Future Pandemics 50%
• Nanoparticles 50%
• High Density 50%
• Capsid 50%
• Humoral Response 50%
• Capsid Binding 50%
• Structural Stability 50%
• Low-middle Income 50%
• High Thermals 50%
• Vaccine Access 50%
• MRNA Vaccine 50%
• Rapid Deployment 50%
• Rapid Design 50%
• T4 Phage 50%

Medicine and Dentistry

• Enterobacteria Phage T4 100%
• Virus Capsid 66%
• Protein Binding 33%
• Immune Response 33%
• Health Care Cost 33%
• Pathogen 33%
• COVID-19 33%
• Mucosal Immunity 33%
• mRNA Vaccine 33%
• Nanoparticle 33%
• Bacteriophage 33%
• Pandemic 33%

Immunology and Microbiology

• Enterobacteria Phage T4 100%
• Capsid 66%
• Immune Response 33%
• Protein Binding 33%
• Bacteriophage 33%
• Infectious Agent 33%
• COVID-19 33%
• Mucosal Immunity 33%
• Vaccinology 33%